Subject
Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science
Reference11 articles.
1. Pneumococcal macrolide resistance—myth or reality?
2. Breen J, Chandra R, Herbig S, etal 2005. Zmax: a novel microsphere-based azithromycin dosage form. American Association of Pharmaceutical Scientists [poster]. Nov 6-10, 2005; Nashville TN, USA.
3. Craig WA, Kiem S, Andes DR. 2002. Free Drug 24-Hr AUC/MIC is the PK/PD target that correlates with in vivo efficacy of macrolides, azolide, ketolides and clindamycin [abstract A-1264]. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. September 27-30, 2002; San Diego, CA, USA.
4. Novel, Single-Dose Microsphere Formulation of Azithromycin versus 7-Day Levofloxacin Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults
5. Single-Dose Azithromycin Microspheres vs Clarithromycin Extended Release for the Treatment of Mild-to-Moderate Community-Acquired Pneumonia in Adults
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献